PIK3CA and cancer: Through inhibition of prenylation of Ras and Rho proteins, statins may suppress extensive downstream signalling pathways of these proteins, such as the PI3K/Akt/mTOR and MAPK/ERK pathways, which are commonly abrogated in many types of cancer.